
GC32808
Selitrectinib
Also listed as Selitrectinib (LOXO-195)
Selitrectinib (LOXO-195) (LOXO-195) is a next-generation TRK kinase inhibitor, with IC50s of 0·6 nM and <2·5 nM for TRKA and TRKC, respectively
ChemicalCAS2097002-61-2MW380.42FormulaC20H21FN6O
- CAS number
- 2097002-61-2
- Molecular weight
- 380.42
- Formula
- C20H21FN6O
- Solubility
- DMSO : 62·5 mg/mL (164·29 mM)
- InChIKey
- OEBIHOVSAMBXIB-SJKOYZFVSA-N
- Catalogue number
- GC32808
- Brand
- GLPBIO
Computed properties PubChem CID 129103609 · XLogP 2 · TPSA 75.4 Ų · H-bond donors 1
- XLogP
- 2
- TPSA
- 75.4 Ų
- H-bond donors
- 1
- H-bond acceptors
- 6
- Rotatable bonds
- 0
- Heavy atoms
- 28
SMILES C[C@@H]1CCC2=C(C=C(C=N2)F)[C@H]3CCCN3C4=NC5=C(C=NN5C=C4)C(=O)N1
Computed descriptors from PubChem (CID 129103609), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il